Catalent is taking aim at the Asian market with a partnership with Mitsubishi Gas Chemical Company to make cell lines for the region. The firms announced plans to jointly market Catalent's GPEx, a vector for mammalian cell lines, for preclinical screening uses and as a CMO service producing finished biopharmaceuticals.
http://ift.tt/1zuTdSR?
http://ift.tt/1zuTdSR?
No comments:
Post a Comment